Cargando…
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date
Osteoarthritis (OA) is a complex heterogeneous articular disease with multiple joint tissue involvement of varying severity and no regulatory-agency-approved disease-modifying drugs (DMOADs). In this review, we discuss the reasons necessitating the development of DMOADs for OA management, the classi...
Autores principales: | Oo, Win Min, Little, Christopher, Duong, Vicky, Hunter, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273751/ https://www.ncbi.nlm.nih.gov/pubmed/34262259 http://dx.doi.org/10.2147/DDDT.S295224 |
Ejemplares similares
-
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022) -
IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis
Model
por: van Helvoort, E.M., et al.
Publicado: (2021) -
Associations between radiographic features, clinical features and ultrasound of thumb‐base osteoarthritis: A secondary analysis of the COMBO study
por: Shi, Ying, et al.
Publicado: (2021) -
Musculoskeletal ultrasound in symptomatic thumb-base osteoarthritis: clinical, functional, radiological and muscle strength associations
por: Oo, Win Min, et al.
Publicado: (2019) -
Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression
por: Guermazi, Ali, et al.
Publicado: (2023)